Elaitra Ltd

Elaitra Ltd

Medical Imaging & Radiology

About Elaitra Ltd

Elaitra Ltd is a medical imaging AI company focused on improving breast cancer detection through Digital Breast Tomosynthesis (DBT) imaging. The company addresses the critical challenge that late breast cancer detection costs approximately 30,000 lives annually in the USA alone. Elaitra's AI platform comprises two key products: BreastGPT, which engages patients in the screening process, and ViewFinder, which assists radiologists in reading DBT images more efficiently. The technology aims to solve detection's worst pain-points by making the reading process faster and more accurate. According to user feedback, 92% of practitioners would use Elaitra in their practice, with radiologists noting that the platform helps them find lesions more accurately and efficiently. The company targets the breast cancer screening market, which is particularly significant given that breast cancer is the world's most prevalent cancer. Elaitra's solution is designed to accelerate the diagnostic workflow while improving detection accuracy, addressing both efficiency and clinical outcome challenges in radiology practices.

Clinical Focus

Medical conditions and clinical areas addressed by Elaitra Ltd.

breast cancer

Who It Serves

radiology practicesbreast imaging centershealthcare providers

Company Details

Headquarters
San Francisco, CA, USA

Work here?

Claim this listing to update company information and connect with our audience.

Claim This Listing

Official Sources

Last updated Jun 29, 2026

Similar Companies in this Market

View all 189
A2z Radiology Ai

A2z Radiology Ai

AI platform that triages urgent abdomen-pelvis CT findings and prioritizes flagged studies in radiology worklists.

Adas3D Medical S.L

Adas3D Medical S.L

11-50 employees

Adas3D Medical develops medical imaging software that extracts key clinical information from cardiac MRI and CT scans for electrophysiologists. The software helps plan, guide, and monitor catheter ablation procedures by visualizing and quantifying fibrotic tissue in the heart.

AEYE Health

AEYE Health

11-50 employees

AEYE Health provides FDA-cleared autonomous AI diagnostic screening for diabetic retinopathy and other eye diseases using retinal images. Their point-of-care solution enables primary care physicians to screen and diagnose patients instantly with portable or desktop cameras.

Agfa HealthCare N.V.

Agfa HealthCare N.V.

AGFA HealthCare provides enterprise imaging platforms that unify medical imaging across specialties. The company delivers PACS, vendor neutral archives, AI-powered workflow orchestration, and cloud-based imaging solutions to hospitals and healthcare systems worldwide.

AI4MedImaging Medical Solutions

AI4MedImaging Medical Solutions

AI4MedImaging provides AI-powered medical imaging solutions distributed through aycan Medical Systems in the Americas. Their flagship product, AI4CMR, is software as a medical device (SaMD) that automates the interpretation of cardiac magnetic resonance imaging using artificial intelligence.

Aidence

Aidence

Aidence, now part of DeepHealth, develops AI-powered clinical applications for radiology and medical imaging. The company specializes in lung nodule detection, classification, and patient management solutions that empower radiologists and physicians in interpreting medical images.

Aidoc

Aidoc

growth · 350 employees

Aidoc empowers health systems to improve patient outcomes and operations with enterprise-grade healthcare AI.

Aikenist Technologies Pvt Ltd

Aikenist Technologies Pvt Ltd

21-100 employees

Aikenist Technologies is a MedTech company specializing in advanced AI-driven solutions for radiology imaging. Their offerings include an FDA-approved AI PACS and RIS with integrated viewer, appointment scheduling, billing modules, and AI tools for stroke, oncology, and neuro detection.

Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.